| ASSET | QUARTER | % RETURN |
|---|---|---|
BTCS (BTCS) | Q2 2010 | 16,234.8% |
Heritage Global (HGBL) | Q2 2010 | 837.5% |
Niagen Bioscience (NAGE) | Q2 2010 | 229.79% |
Enveric Biosciences (ENVB) | Q2 2010 | 204% |
NextTrip (NTRP) | Q2 2010 | 180% |
Hirequest (HQI) | Q2 2010 | 160% |
QXO (QXO) | Q2 2010 | 125% |
Neurocrine Biosciences (NBIX) | Q2 2010 | 118.75% |
inTest (INTT) | Q2 2010 | 115.2% |
Red Cat (RCAT) | Q2 2010 | 108.7% |
LGL (LGL) | Q2 2010 | 98.23% |
IDT (IDT) | Q2 2010 | 96.15% |
Yunhong Green CTI (YHGJ) | Q2 2010 | 88.97% |
Cirrus Logic (CRUS) | Q2 2010 | 88.21% |
Metalla Royalty & Streaming (MTA) | Q2 2010 | 85.84% |
McEwen Mining (MUX) | Q2 2010 | 83.51% |
Escalade (ESCA) | Q2 2010 | 82.53% |
Neonode (NEON) | Q2 2010 | 80% |
Radcom (RDCM) | Q2 2010 | 75.44% |
ACCESS Newswire (ACCS) | Q2 2010 | 73.33% |
TriMas (TRS) | Q2 2010 | 73.2% |
Armata Pharmaceuticals (ARMP) | Q2 2010 | 72.73% |
Champions Oncology (CSBR) | Q2 2010 | 67.27% |
Astronics (ATRO) | Q2 2010 | 66.94% |
374Water Inc Common Stock (SCWO) | Q2 2010 | 66.67% |
